180 related articles for article (PubMed ID: 28502870)
1. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
[TBL] [Abstract][Full Text] [Related]
2. Analysis of early failure of Biotronik Linox Smart implantable cardioverter-defibrillator leads: A comparative study of three defibrillator leads.
Pérez Díez D; Rubín JM; Calvo Cuervo D; García Iglesias D; Morís De La Tassa C
Pacing Clin Electrophysiol; 2018 Sep; 41(9):1165-1170. PubMed ID: 29894002
[TBL] [Abstract][Full Text] [Related]
3. Failure rate and conductor externalization in the Biotronik Linox/Sorin Vigila implantable cardioverter-defibrillator lead.
Noti F; Lam A; Klossner N; Seiler J; Servatius H; Medeiros-Domingo A; Nam Tran V; Haeberlin A; Fuhrer J; Tanner H; Roten L
Heart Rhythm; 2016 May; 13(5):1075-1082. PubMed ID: 26738946
[TBL] [Abstract][Full Text] [Related]
4. Long-term single-center comparison of ICD lead survival: Evidence for premature Linox lead failure.
O'Connor M; Hooks D; Webber M; Shi B; Morrison S; Harding S; Larsen P
J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1024-1031. PubMed ID: 29656578
[TBL] [Abstract][Full Text] [Related]
5. Performance of the Linox implantable cardioverter defibrillator leads: A single-center experience.
Marai I; Milman A; Nof E; Gurevitz O; Barlev D; Lipchenca I; Bachar S; Glikson M; Beinart R
Pacing Clin Electrophysiol; 2019 Dec; 42(12):1524-1528. PubMed ID: 31602668
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the performance of implantable cardioverter-defibrillator leads among manufacturers.
Kondo Y; Nakano M; Kajiyama T; Nakano M; Hayashi T; Ito R; Takahira H; Kobayashi Y
J Interv Card Electrophysiol; 2020 Aug; 58(2):133-139. PubMed ID: 31691064
[TBL] [Abstract][Full Text] [Related]
8. Early ICD lead failure in defibrillator systems with multiple leads via cephalic access.
Barbhaiya CR; Niazi O; Bostrom J; Patil S; Jankelson L; Bernstein S; Park D; Holmes D; Aizer A; Chinitz LA
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1462-1469. PubMed ID: 32356380
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the failure rates among 3 implantable defibrillator leads.
van Malderen SC; Szili-Torok T; Yap SC; Hoeks SE; Zijlstra F; Theuns DA
Heart Rhythm; 2016 Dec; 13(12):2299-2305. PubMed ID: 27496586
[TBL] [Abstract][Full Text] [Related]
10. First time description of early lead failure of the Linox Smart lead compared to other contemporary high-voltage leads.
Weberndörfer V; Nyffenegger T; Russi I; Brinkert M; Berte B; Toggweiler S; Kobza R
J Interv Card Electrophysiol; 2018 Jul; 52(2):173-177. PubMed ID: 29713860
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.
Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C
Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626
[TBL] [Abstract][Full Text] [Related]
12. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
Hauser RG; Hayes DL
Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
[TBL] [Abstract][Full Text] [Related]
13. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
[TBL] [Abstract][Full Text] [Related]
14. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
[TBL] [Abstract][Full Text] [Related]
15. Impact of fracture-prone implantable cardioverter defibrillator leads on long-term patient mortality.
Koike T; Shoda M; Ejima K; Yagishita D; Suzuki A; Hasegawa S; Kataoka S; Yazaki K; Higuchi S; Kanai M; Yamaguchi J
J Arrhythm; 2023 Jun; 39(3):454-463. PubMed ID: 37324755
[TBL] [Abstract][Full Text] [Related]
16. Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families.
Liu J; Brumberg G; Rattan R; Jain S; Saba S
Heart Rhythm; 2012 Aug; 9(8):1251-5. PubMed ID: 22484652
[TBL] [Abstract][Full Text] [Related]
17. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
Ellis CR; Rottman JN
Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
[TBL] [Abstract][Full Text] [Related]
18. Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience.
Alasti M; Machado C; Mirzaee S; Healy S; Bittinger L; Adam D; Kotschet E; Krafchek J; Alison J
J Interv Card Electrophysiol; 2021 Jun; 61(1):115-121. PubMed ID: 32488749
[TBL] [Abstract][Full Text] [Related]
19. Update on small-diameter implantable cardioverter-defibrillator leads performance.
van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
[TBL] [Abstract][Full Text] [Related]
20. Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
Providência R; Kramer DB; Pimenta D; Babu GG; Hatfield LA; Ioannou A; Novak J; Hauser RG; Lambiase PD
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26518666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
